NeuroCDRD, a new drug development platform jointly led by CDRD, the Montreal Neurological Institute and Hospital at McGill University (MNI), & Merck aims to accelerate the development of new treatments for ALS and Parkinson’s disease.
Join CDRD & top cancer researchers and clinicians from across Canada to learn about novel platforms in cancer immunotherapy research, implications for the discovery of therapeutic candidates, lessons learned, and to discuss how novel platforms may advance cancer immunotherapy R&D in Canada.
We enjoyed meeting everyone at the BC Tech Summit!
Thanks to Jason Crawford, our VP of Scientific Operations for participating in the Innovating Healthcare panel along with our partners Zymeworks, Stemcell Technologies, Innovation Boulevard & UBC
CDRD is proud to a founding partner of the Regenerative Medicine Alliance of Canada along with other founding members: CCRM; CellCan; Medicine by Design; Ontario Institute for Regenerative Medicine; ThéCell; Canadian Stem Cell Foundation, and Stem Cell Network.
CDRD and national partners are hosting the BC Research Symposium on May 10th.
Save the date! More details soon.
CDRD is a partner in one of 16 new collaborative research projects announced by BioCanRx. These projects are aimed at finding improved treatment options and outcomes for cancer patients and developing clinical Chimeric Antigen Receptor modified T cell (CAR-T) manufacturing capabilities in Canada.
CDRD Expands Global Industry Partnerships with Addition of AstraZeneca!
This private/public partnership will continue to support Canadian health research projects by advancing promising research from the university labs through independent testing and validation and towards clinical trials and commercialization.
Health sciences researchers, entrepreneurs, and companies alike have the opportunity to collaborate with CDRD and thereby access its full suite of expertise, infrastructure, and broad partnerships and networks.
CDRD BY THE NUMBERS:
Headquartered in Vancouver, British Columbia, The Centre for Drug Research and Development (CDRD) is Canada’s national drug development and commercialization engine.
We work in partnership with academia, industry, government and foundations, to provide the specialized expertise and infrastructure to identify and de-risk promising discoveries generated by health-related research, and transform them into commercially viable investment opportunities for the private sector – and ultimately into innovative new therapies for patients.
In doing so, CDRD is actively growing our national health sciences industry into a wholly-optimized generator of economic prosperity for the country.
Since 2008, Canada’s Networks of Centres of Excellence Program has recognized CDRD as a Centre of Excellence for Commercialization and Research (CECR).